How to switch an adult patient with chronic conditions like diabetes or hypertension from 60 units of one medication to another?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Switch from 60 Units of One Medication to Another

Stop the first medication and start the new medication the next day without a washout period, as recommended by the American College of Cardiology for most antihypertensive medications and the American Geriatrics Society for chronic condition medications. 1

General Switching Protocol

The American Heart Association defines medication switching as stopping one medication and starting another "at approximately the same time," interpreted as within one month or the duration of one medication refill. 1 For adult patients with chronic conditions like diabetes or hypertension, the following approach applies:

Immediate Switching (Next-Day Start)

  • Stop the current medication and begin the new medication the following day without any washout period for most antihypertensive agents. 1, 2
  • This direct switching approach is safe and effective for ACE inhibitors, ARBs, calcium channel blockers, and diuretics. 1, 2
  • The only exception requiring caution involves medications acting on the cardiovascular or central nervous system, where closer monitoring is warranted. 1

Dose Conversion Considerations

For Insulin Switching

When converting between different insulin formulations, specific dose adjustments may be necessary:

  • Convert unit-for-unit initially, then adjust based on glucose monitoring for most insulin switches. 3
  • Reduce the initial dose by 10-20% when switching to a different basal insulin in patients with very tight glycemic control or high hypoglycemia risk. 3
  • This dose reduction is typically needed when switching from insulin detemir or U-300 glargine to another insulin formulation. 3
  • Insulin glargine should never be mixed with other insulin forms due to its low pH diluent. 3

For Antihypertensive Medications

  • Most antihypertensive switches can be done at equivalent doses without initial reduction. 1, 2
  • When switching from lisinopril/HCTZ to losartan/HCTZ, stop the ACE inhibitor combination and start the ARB combination the next day at the target dose. 2
  • Both ACE inhibitors and ARBs are first-line agents with similar efficacy and safety profiles, making direct switching appropriate. 2

Critical Pre-Switching Steps

Before initiating any medication switch, complete these mandatory assessments:

  • Obtain detailed history of previous symptoms and medication responses from the patient, family members, and medical records. 1
  • Review previous clinician notes to understand why the current medication was chosen and any prior medication failures. 1
  • Document the specific reasons for switching after thorough discussion with the patient. 1
  • Develop a detailed monitoring plan for the post-switch period. 1

Contraindications to Direct Switching

Absolute Contraindications

  • Recent acute kidney injury or hyperkalemia contraindicates switching between ACE inhibitors and ARBs, as both classes can worsen these conditions, particularly when combined with diuretics. 2
  • Pregnancy is an absolute contraindication to both ACE inhibitors and ARBs due to fetal toxicity. 2

Situations Requiring Caution

  • Never combine ACE inhibitors with ARBs during the switching process, as dual RAAS blockade increases risk of end-stage renal disease and stroke. 3
  • Avoid overlapping doses of the old and new medication except in specific psychiatric medication switches where brief overlap may be necessary. 1

Post-Switch Monitoring Requirements

Blood Pressure Monitoring

  • Monitor blood pressure closely in elderly patients after switching antihypertensive medications, as hypotension or orthostatic hypotension may develop. 1
  • Review and adjust doses every 2-4 weeks until blood pressure control is established. 3

Glucose Monitoring

  • Increase glucose monitoring frequency when switching insulin formulations to detect hypoglycemia or hyperglycemia early. 3
  • Watch for signs of overbasalization with insulin therapy, including bedtime-to-morning glucose differential ≥50 mg/dL or high glucose variability. 3

Alternative Strategies to Consider

When to Add Rather Than Switch

  • Consider adding a calcium channel blocker instead of switching again if blood pressure remains uncontrolled on the current two-drug regimen. 1, 2
  • For hypertension requiring three drugs, combine an ACE inhibitor or ARB with a calcium channel blocker and a diuretic. 3
  • Most hypertensive patients require two or more medications to achieve blood pressure goals. 3

Augmentation vs. Switching

  • For diabetes management, adding a GLP-1 RA or dual GIP/GLP-1 RA to basal insulin should be considered before advancing to multiple prandial insulin doses. 3
  • This approach addresses postprandial hyperglycemia while reducing hypoglycemia and weight gain risks associated with insulin intensification. 3

Common Pitfalls to Avoid

  • Do not inadvertently change insulin type when a patient is admitted to the hospital without physician approval and patient notification. 3
  • Avoid thiazide-diuretic combinations with beta-blockers when possible, as this increases diabetes risk. 3
  • Do not use fixed-dose combinations at starting doses below those proven effective in clinical trials without planning to titrate upward. 3
  • Never assume medication "left over" from previous prescriptions when calculating treatment discontinuation or switching timelines. 3

References

Guideline

Switching Medications in Patients with Chronic Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Switching from Lisinopril/HCTZ to Losartan/HCTZ

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the appropriate management for a patient with diabetes or hypertension starting an XR (Extended-Release) 12.5/1000 mg tablet, considering potential renal impairment?
How to switch an adult patient with chronic conditions (e.g. diabetes, hypertension) from 60 units of one medication to another?
What are the latest guidelines for managing patients with chronic conditions such as diabetes or hypertension?
What should be ordered for a patient with potential dietary restrictions due to medical conditions such as diabetes or hypertension?
What is the recommended approach for managing common internal medicine conditions like hypertension and diabetes?
Are Gabapentin and Amitriptyline (tricyclic antidepressant) the same thing?
What is the most appropriate initial intervention for a patient with a history of Chronic Obstructive Pulmonary Disease (COPD), tobacco use, and alcohol use disorder, who underwent an emergent splenectomy for a splenic laceration with hemorrhage, and now presents with severe respiratory distress, hypoxemia, tachypnea, and tachycardia 12 hours post-operatively?
Is a neurological condition likely in a patient with thoracic back pain and a suspected spinal lipoma, but no symptoms outside of back pain?
What is the appropriate use and dosage of dexmethylphenidate for a patient with Attention Deficit Hyperactivity Disorder (ADHD)?
What is the best approach to manage blood pressure in a patient with renal artery stenosis?
Do we need to treat a positive culture in an asymptomatic elderly woman with potential underlying medical conditions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.